Categories
Life Sciences Consumer Goods Materials and Chemicals Construction & Manufacturing Food and Beverages Energy and Power Semiconductor and Electronics Automotive and Transportation ICT & Media Aerospace & Defense BFSI

Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com

Fertility supplement market by Ingredient (Natural and Synthetic/Blend of Natural & Synthetic), Product (Capsules, Tablets, Soft Gels, Powders, and Liquids) and End User (Men and Women): Global Opportunity Analysis and Industry Forecast, 2020–2030

A07134

Pages: 236

Charts: 17

Tables: 88

Fertility supplement market Overview 

The fertility supplements market size generated $1,754.00 million in 2020 and is projected to reach $3,652.50 million by 2030, growing at a CAGR of 7.50% from 2021 to 2030.Fertility supplements have been shown to prompt ovulation, improve hormonal profiles, and increase pregnancy and delivery rates for women and men. Infertility can occur in men or women of child-bearing age. In addition, male infertility is identified majorly as a result of low sperm count or decreased motility of sperms, which may be due to hormonal imbalance. Hence, fertility in men and women requires proper functioning of hypothalamus and pituitary gland. Increase in the rate of infertility has occurred majorly due to factors such as increase in the consumption of alcohol and drugs, increased stress level, frequent smoking, obesity, and environmental factors. As per a study by the American Society for Reproductive medicines, in approximately 40% of infertile couples, the male partner is responsible for infertility and among them, approximately 85%–90% are treated with drugs or surgery. Hence, positively impacting the market growth.

[COVIDIMPACTSTATEMENT]

Various government activities are organized to increase awareness regarding the fertility supplements and further advancements in research and development that have helped the decision markers to choose supplements considering their past illness. At present, many people are focused on improving sexual wellbeing and eager to spend more on fertility supplements, this would drive the growth of the fertility supplement market. 

Get more information on this report : Request Sample Pages

Rise in the fertility rates owing to the increasing consumption of alcoholic beverages, caffeine and smoking is a major factor driving the growth. It is expected to be driven by the declining fertility rates in the quantity of smokers with the rise in the utilization of liquor and caffeine. Rising geriatric population, human services costs, evolving way of life, clinical revelations and assumptions about the significant expenses of fertility supplements have supported the general market development as well as product demand. The fertility medications may not be useful for females undergoing UVR treatment considering the consumption caffeine and smoking is the major factor that impacts the effect of supplements on the body. Further, expanding significance of food items for example avocados, olive oil, entire grains and high fat dairy items utilized in expanding fertility is required to enhance the extent of functional food and drinks in future. The important factors are rising geriatric population and the increasing inclination toward preventive measure for fertility, which includes fertility supplements. Moreover, rise in infertility rates are not only due to lifestyle changes but also due to various diseases such as sexually transmitted diseases (STDs) and fertility-related diseases. Hence, the increase in infertility rates in the near future is anticipated to augment the growth of the fertility supplements market.

[INGREDIENTSGRAPH]

Get more information on this report : Request Sample Pages

Fertility Supplement Market Segmentation

The global fertility supplement market is classified into ingredient, product, end user, and region. By ingredient, the market is divided into natural, and synthetic/blend of natural & synthetic. By product, it is categorized into capsules, tablets, soft gels, powders, and liquids. By end user, the market is segmented into men and women. On the basis of region, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, the UK, France, Spain, Italy, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa and rest of LAMEA).

Segment review

By ingredient, the natural segment accounted for more than half of the market share in fertility supplement market in 2020. This segment is expected to exhibit a prominent growth rate, owing to, introduction of innovative products and technological advancements in health and wellness industry are anticipated to boost the growth of natural fertility supplement segment over the forecast period. Increasing utilization of plant-derived products for a healthy lifestyle and to reduce the risk of side effects is expected to further propel the demand in the near future. Moreover, by product, the capsules segment accounted for major share of the market share in fertility supplement market in 2020. These products enable unique mixes of ingredients, provide protection from sensitive ingredients, reduce gastrointestinal irritation, and ensure oil and fat-soluble nutrient delivery. This factor is anticipated to boost the segment growth.

[PRODUCTGRAPH]

Get more information on this report : Request Sample Pages

By end user, the women segment accounted for major share of the market share in fertility supplement market in 2020. This segment is expected to exhibit a considerable growth rate. Immune system factors, hypogonadism, varicocele, systemic disease, sexual factors, urogenital infection are some of the prominent factors leading to fertility problems in women.

Asia-Pacific presents lucrative opportunities for key players operating in the fertility supplement market, owing to increase in accessibility and availability of healthcare facilities and rise in healthcare and research expenditure. This region is anticipated to experience rapid market growth due to economic development. Moreover, rising awareness in China and India regarding nutritional enrichment is expected to remain a favorable factor for regional growth. Furthermore, expansion in retail market in emerging markets including China, Indonesia, Malaysia, and India in light of regulatory support to promote investments is expected to increase the accessibility to buyers over the forecast period.

[ENDUSERGRAPH]

Get more information on this report : Request Sample Pages

The key players operating in the global fertility supplement market include Fairhaven Health, Coast Science, Lenus Pharma GesmbH, Active Bio Life Science GmbH, Orthomol, Exeltis USA, Inc.,PregPrep LLC, Bionova, TTK HealthCare Ltd.,Fertility Nutraceuticals LLC.

[REGIONGRAPH]

Get more information on this report : Request Sample Pages

Key Benefits For Stakeholders

  • The study provides an in-depth analysis of the fertility supplement market, and the current trends and future estimations to elucidate the imminent investment pockets.
  • It presents a quantitative analysis of the market from 2020 to 2030 to enable stakeholders to capitalize on the prevailing fertility supplements market opportunities.
  • Extensive analysis of the market based on procedures and services assists to understand the trends in the industry.
  • Key players and their strategies are thoroughly analyzed to understand the competitive outlook of the fertility supplements market.

Key Market Segments

By Ingredient

  • Natural
  • Synthetic/Blend of Natural & Synthetic 

By Product

  • Capsules
  • Tablets
  • Soft Gels
  • Powders
  • Liquids

By End User

  • Men
  • Women

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Key Market Segments

  • By INGREDIENTS
    • Natural
    • Synthetic and blend
  • By PRODUCT
    • Capsules
    • Tablets
    • Soft Gels
    • Powders
    • Liquids
  • By END USER
    • Men
    • Women
  • By Region
    • North America
      • U.S.
      • Canada
      • Mexico
    • Europe
      • France
      • Germany
      • Italy
      • Spain
      • UK
      • Russia
      • Rest of Europe
    • Asia-Pacific
      • China
      • Japan
      • India
      • South Korea
      • Australia
      • Thailand
      • Malaysia
      • Indonesia
      • Rest of Asia-Pacific
    • LAMEA
      • Brazil
      • South Africa
      • Saudi Arabia
      • UAE
      • Argentina
      • Rest of LAMEA


Key Market Players

  • Active Bio Life Science GmbH
  • TTK HealthCare Ltd.
  • Bionova
  • Coast Science
  • Fairhaven Health
  • Orthomol
  • Lenus Pharma GesmbH,
  • Exeltis USA, Inc.
  • PregPrep LLC
  • Fertility Nutraceuticals LLC.

CHAPTER 1:INTRODUCTION

1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments

1.3.1.List of key players profiled in the report

1.4.Research methodology

1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools & models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.Key findings of the study
2.2.CXO perspective

CHAPTER 3:MARKET OVERVIEW

3.1.Market definition and scope
3.2.Key findings

3.2.1.Top investment pockets

3.3.Porter’s five force analysis
3.4.Market dynamics

3.4.1.Drivers

3.4.1.1.Continuous decline in fertility rates
3.4.1.2.Delayed pregnancies in women

3.4.2.Restraints

3.4.2.1.Technological advancements with respect to fertility treatment restrain the market growth

3.4.3.Opportunity

3.4.3.1.Rising demand for natural ingredients

3.5.COVID-19 impact on the fertility supplements market

3.5.1.Overview
3.5.2.Impact analysis

CHAPTER 4:FERTILITY SUPPLEMENTS MARKET, BY INGREDIENTS

4.1.Overview

4.1.1.Market size and forecast

4.2.Natural

4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast
4.2.3.Market analysis, by country

4.3.Synthetic and blend

4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast
4.3.3.Market analysis, by country

CHAPTER 5:FERTILITY SUPPLEMENTS MARKET, BY PRODUCT

5.1.Overview

5.1.1.Market size and forecast

5.2.Capsules

5.2.1.Market size and forecast
5.2.2.Market analysis, by country

5.3.Tablets

5.3.1.Market size and forecast
5.3.2.Market analysis, by country

5.4.Soft Gels

5.4.1.Market size and forecast
5.4.2.Market analysis, by country

5.5.Powders

5.5.1.Market size and forecast
5.5.2.Market analysis, by country

5.6.Liquids

5.6.1.Market size and forecast
5.6.2.Market analysis, by country

CHAPTER 6:FERTILITY SUPPLEMENTS MARKET, BY END USER

6.1.Overview

6.1.1.Market size and forecast

6.2.Men

6.2.1.Market size and forecast
6.2.2.Market analysis, by country
6.2.2.1.Market size and forecast, by product

6.3.Women

6.3.1.Market size and forecast
6.3.2.Market analysis, by country
6.3.2.1.Market size and forecast, by product

CHAPTER 7:FERTILITY SUPPLEMENTS MARKET, BY REGION

7.1.Overview

7.1.1.Market size and forecast

7.2.North America

7.2.1.Key market trends, growth factors, and opportunities
7.2.2.Market size and forecast, by country
7.2.3.Market size and forecast, By ingredients
7.2.4.Market size and forecast, By product
7.2.5.Market size and forecast, by end user

7.2.5.1.U.S.

7.2.5.2.U.S. market size and forecast, By ingredients
7.2.5.3.U.S. Market size and forecast, By product
7.2.5.4.U.S. Market size and forecast, by end user

7.2.5.5.Canada

7.2.5.6.Market size and forecast, By ingredients
7.2.5.7.Canada Market size and forecast, By product
7.2.5.8.Canada Market size and forecast, by end user

7.2.5.9.Mexico

7.2.5.10.Market size and forecast, By ingredients
7.2.5.11.Mexico Market size and forecast, By product
7.2.5.12.Mexico Market size and forecast, by end user

7.3.Europe

7.3.1.Key market trends, growth factors, and opportunities
7.3.2.Europe Market size and forecast, by country
7.3.3.Europe Market size and forecast, By ingredients
7.3.4.Europe market size and forecast, By product
7.3.5.Europe market size and forecast, by end user

7.3.5.1.Germany

7.3.5.2.Market size and forecast, By ingredients
7.3.5.3.Germany market size and forecast, By product
7.3.5.4.Germany market size and forecast, by end user

7.3.5.5.France

7.3.5.6.Market size and forecast, By ingredients
7.3.5.7.France market size and forecast, By product
7.3.5.8.France market size and forecast, by end user

7.3.5.9.UK

7.3.5.10.Market size and forecast, By ingredients
7.3.5.11.UK market size and forecast, By product
7.3.5.12.UK market size and forecast, by end user

7.3.5.13.Italy

7.3.5.14.Market size and forecast, By ingredients
7.3.5.15.Italy Market size and forecast, By product
7.3.5.16.Italy market size and forecast, by end user

7.3.5.17.Spain

7.3.5.18.Market size and forecast, By ingredients
7.3.5.19.Spain Market size and forecast, By product
7.3.5.20.Spain Market size and forecast, by end user

7.3.5.21.Rest of Europe

7.3.5.22.Market size and forecast, By ingredients
7.3.5.23.Rest of Europe market size and forecast, By product
7.3.5.24.Rest of Europe market size and forecast, by end user

7.4.Asia-Pacific

7.4.1.Key market trends, growth factors, and opportunities
7.4.2.Market size and forecast, by country
7.4.3.Asia-Pacific market size and forecast, By ingredients
7.4.4.Asia-Pacific market size and forecast, By product
7.4.5.Asia-Pacific market size and forecast, by end user

7.4.5.1.Japan

7.4.5.2.Market size and forecast, By ingredients
7.4.5.3.Japan market size and forecast, By product
7.4.5.4.Japan market size and forecast, by end user

7.4.5.5.India

7.4.5.6.Market size and forecast, By ingredients
7.4.5.7.India Market size and forecast, By product
7.4.5.8.India market size and forecast, by end user

7.4.5.9.China

7.4.5.10.market size and forecast, By ingredients
7.4.5.11.China Market size and forecast, By product
7.4.5.12.China Market size and forecast, by end user

7.4.5.13.Australia

7.4.5.14.Market size and forecast, By ingredients
7.4.5.15.Australia market size and forecast, By product
7.4.5.16.Australia Market size and forecast, by end user

7.4.5.17.South Korea

7.4.5.18.Market size and forecast, By ingredients
7.4.5.19.South Korea market size and forecast, By product
7.4.5.20.South Korea market size and forecast, by end user
7.4.5.21.Rest of Asia-Pacific
7.4.5.22.Market size and forecast, By ingredients
7.4.5.23.Rest of Asia-Pacific Market size and forecast, By product
7.4.5.24.Rest of Asia-Pacific market size and forecast, by end user

7.5.LAMEA

7.5.1.Key market trends, growth factors, and opportunities
7.5.2.Market size and forecast, by country
7.5.3.LAMEA market size and forecast, By ingredients
7.5.4.LAMEA market size and forecast, By product
7.5.5.LAMEA market size and forecast, by end user

7.5.5.1.Brazil

7.5.5.2.Market size and forecast, By ingredients
7.5.5.3.Brazil market size and forecast, By product
7.5.5.4.Brazil market size and forecast, by end user

7.5.5.5.Saudi Arabia

7.5.5.6.Market size and forecast, by ingredients
7.5.5.7.Saudi Arabia market size and forecast, By product
7.5.5.8.Saudi Arabia market size and forecast, by end user

7.5.5.9.South Africa

7.5.5.10.market size and forecast, by ingredients
7.5.5.11.South Africa market size and forecast, By product
7.5.5.12.South Africa market size and forecast, by end user
7.5.5.13.Rest of LAMEA
7.5.5.14.market size and forecast, by ingredients
7.5.5.15.Rest of LAMEA market size and forecast, By product
7.5.5.16.Rest of LAMEA market size and forecast, by end user

LIST OF TABLES

TABLE 01.FERTILITY SUPPLEMENTS MARKET, BY INGREDIENTS, 2020–2030 ($MILLION)
TABLE 02.FERTILITY SUPPLEMENTS MARKET FOR NATURAL, BY REGION, 2020–2030 ($MILLION)
TABLE 03.FERTILITY SUPPLEMENTS MARKET FOR SYNTHETIC AND BLEND, BY REGION, 2020–2030 ($MILLION)
TABLE 04.FERTILITY SUPPLEMENTS MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 05.FERTILITY SUPPLEMENTS MARKET FOR CAPSULES, BY REGION, 2020-2030 ($MILLION)
TABLE 06.FERTILITY SUPPLEMENTS MARKET FOR TABLETS, BY REGION, 2020-2030 ($MILLION)
TABLE 07.FERTILITY SUPPLEMENTS MARKET FOR SOFT GELS, BY REGION, 2020-2030 ($MILLION)
TABLE 08.FERTILITY SUPPLEMENTS MARKET FOR POWDERS, BY REGION, 2020-2030 ($MILLION)
TABLE 09.FERTILITY SUPPLEMENTS MARKET FOR LIQUIDS, BY REGION, 2020-2030 ($MILLION)
TABLE 10.FERTILITY SUPPLEMENTS MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 11.FERTILITY SUPPLEMENTS MARKET FOR MEN, BY REGION, 2020-2030 ($MILLION)
TABLE 12.FERTILITY SUPPLEMENTS MARKET FOR MEN, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 13.FERTILITY SUPPLEMENTS MARKET FOR WOMEN, BY REGION, 2020-2030 ($MILLION)
TABLE 14.FERTILITY SUPPLEMENTS MARKET FOR WOMEN, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 15.FERTILITY SUPPLEMENTS MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 16.NORTH AMERICA FERTILITY SUPPLEMENTS MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 17.NORTH AMERICA FERTILITY SUPPLEMENTS MARKET, BY INGREDIENTS, 2020-2030 ($MILLION)
TABLE 18.NORTH AMERICA FERTILITY SUPPLEMENTS MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 19.NORTH AMERICA FERTILITY SUPPLEMENTS MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 20.U.S. FERTILITY SUPPLEMENTS MARKET, BY INGREDIENTS, 2020-2030 ($MILLION)
TABLE 21.U.S. FERTILITY SUPPLEMENTS MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 22.U.S. FERTILITY SUPPLEMENTS MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 23.CANADA FERTILITY SUPPLEMENTS MARKET, BY INGREDIENTS, 2020-2030 ($MILLION)
TABLE 24.CANADA FERTILITY SUPPLEMENTS MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 25.CANADA FERTILITY SUPPLEMENTS MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 26.MEXICO FERTILITY SUPPLEMENTS MARKET, BY INGREDIENTS, 2020-2030 ($MILLION)
TABLE 27.MEXICO FERTILITY SUPPLEMENTS MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 28.MEXICO FERTILITY SUPPLEMENTS MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 29.EUROPE FERTILITY SUPPLEMENTS MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 30.EUROPE FERTILITY SUPPLEMENTS MARKET, BY INGREDIENTS, 2020-2030 ($MILLION)
TABLE 31.EUROPE FERTILITY SUPPLEMENTS MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 32.EUROPE FERTILITY SUPPLEMENTS MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 33.GERMANY FERTILITY SUPPLEMENTS MARKET, BY INGREDIENTS, 2020-2030 ($MILLION)
TABLE 34.GERMANY FERTILITY SUPPLEMENTS MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 35.GERMANY FERTILITY SUPPLEMENTS MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 36.FRANCE FERTILITY SUPPLEMENTS MARKET, BY INGREDIENTS, 2020-2030 ($MILLION)
TABLE 37.FRANCE FERTILITY SUPPLEMENTS MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 38.FRANCE FERTILITY SUPPLEMENTS MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 39.UK FERTILITY SUPPLEMENTS MARKET, BY INGREDIENTS, 2020-2030 ($MILLION)
TABLE 40.UK FERTILITY SUPPLEMENTS MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 41.UK FERTILITY SUPPLEMENTS MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 42.ITALY FERTILITY SUPPLEMENTS MARKET, BY INGREDIENTS, 2020-2030 ($MILLION)
TABLE 43.ITALY FERTILITY SUPPLEMENTS MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 44.ITALY FERTILITY SUPPLEMENTS MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 45.SPAIN FERTILITY SUPPLEMENTS MARKET, BY INGREDIENTS, 2020-2030 ($MILLION)
TABLE 46.SPAIN FERTILITY SUPPLEMENTS MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 47.SPAIN FERTILITY SUPPLEMENTS MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 48.REST OF EUROPE FERTILITY SUPPLEMENTS MARKET, BY INGREDIENTS, 2020-2030 ($MILLION)
TABLE 49.REST OF EUROPE FERTILITY SUPPLEMENTS MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 50.REST OF EUROPE FERTILITY SUPPLEMENTS MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 51.ASIA-PACIFIC FERTILITY SUPPLEMENTS MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 52.ASIA-PACIFIC FERTILITY SUPPLEMENTS MARKET, BY INGREDIENTS, 2020-2030 ($MILLION)
TABLE 53.ASIA-PACIFIC FERTILITY SUPPLEMENTS MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 54.ASIA-PACIFIC FERTILITY SUPPLEMENTS MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 55.JAPAN FERTILITY SUPPLEMENTS MARKET, BY INGREDIENTS, 2020-2030 ($MILLION)
TABLE 56.JAPAN FERTILITY SUPPLEMENTS MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 57.JAPAN FERTILITY SUPPLEMENTS MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 58.INDIA FERTILITY SUPPLEMENTS MARKET, BY INGREDIENTS, 2020-2030 ($MILLION)
TABLE 59.INDIA FERTILITY SUPPLEMENTS MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 60.INDIA FERTILITY SUPPLEMENTS MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 61.CHINA FERTILITY SUPPLEMENTS MARKET, BY INGREDIENTS, 2020-2030 ($MILLION)
TABLE 62.CHINA FERTILITY SUPPLEMENTS MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 63.CHINA FERTILITY SUPPLEMENTS MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 64.AUSTRALIA FERTILITY SUPPLEMENTS MARKET, BY INGREDIENTS, 2020-2030 ($MILLION)
TABLE 65.AUSTRALIA FERTILITY SUPPLEMENTS MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 66.AUSTRALIA FERTILITY SUPPLEMENTS MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 67.SOUTH KOREA FERTILITY SUPPLEMENTS MARKET, BY INGREDIENTS, 2020-2030 ($MILLION)
TABLE 68.SOUTH KOREA FERTILITY SUPPLEMENTS MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 69.SOUTH KOREA FERTILITY SUPPLEMENTS MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 70.REST OF ASIA-PACIFIC FERTILITY SUPPLEMENTS MARKET, BY INGREDIENTS, 2020-2030 ($MILLION)
TABLE 71.REST OF ASIA-PACIFIC FERTILITY SUPPLEMENTS MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 72.REST OF ASIA-PACIFIC FERTILITY SUPPLEMENTS MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 73.LAMEA FERTILITY SUPPLEMENTS MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 74.LAMEA FERTILITY SUPPLEMENTS MARKET, BY INGREDIENTS, 2020-2030 ($MILLION)
TABLE 75.LAMEA FERTILITY SUPPLEMENTS MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 76.LAMEA FERTILITY SUPPLEMENTS MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 77.BRAZIL FERTILITY SUPPLEMENTS MARKET, BY INGREDIENTS, 2020-2030 ($MILLION)
TABLE 78.BRAZIL FERTILITY SUPPLEMENTS MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 79.BRAZIL FERTILITY SUPPLEMENTS MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 80.SAUDI ARABIA FERTILITY SUPPLEMENTS MARKET, BY INGREDIENTS, 2020-2030 ($MILLION)
TABLE 81.SAUDI ARABIA FERTILITY SUPPLEMENTS MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 82.SAUDI ARABIA FERTILITY SUPPLEMENTS MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 83.SOUTH AFRICA FERTILITY SUPPLEMENTS MARKET, BY INGREDIENTS, 2020-2030 ($MILLION)
TABLE 84.SOUTH AFRICA FERTILITY SUPPLEMENTS MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 85.SOUTH AFRICA FERTILITY SUPPLEMENTS MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 86.REST OF LAMEA FERTILITY SUPPLEMENTS MARKET, BY INGREDIENTS, 2020-2030 ($MILLION)
TABLE 87.REST OF LAMEA FERTILITY SUPPLEMENTS MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 88.REST OF LAMEA FERTILITY SUPPLEMENTS MARKET, BY END USER, 2020-2030 ($MILLION)

LIST OF FIGURES

FIGURE 01.FERTILITY SUPPLEMENTS MARKET: MARKET SEGMENTATION
FIGURE 02.TOP INVESTMENT POCKETS
FIGURE 03.HIGH BARGAINING POWER OF BUYERS
FIGURE 04.MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 05.MODERATE THREAT OF SUBSTITUTION
FIGURE 06.HIGH THREAT OF NEW ENTRANT
FIGURE 07.MODERATE COMPETITIVE RIVALRY
FIGURE 08.MARKET DYNAMICS
FIGURE 09.FERTILITY SUPPLEMENTS MARKET REVENUE FOR NATURAL, BY COUNTRY, 2020–2030(%)
FIGURE 10.FERTILITY SUPPLEMENTS MARKET REVENUE FOR SYNTHETIC AND BLEND, BY COUNTRY, 2020–2030(%)
FIGURE 11.FERTILITY SUPPLEMENTS MARKET REVENUE FOR CAPSULES, BY COUNTRY, 2020–2030(%)
FIGURE 12.FERTILITY SUPPLEMENTS MARKET REVENUE FOR TABLETS, BY COUNTRY, 2020–2030(%)
FIGURE 13.FERTILITY SUPPLEMENTS MARKET REVENUE FOR SOFT GELS, BY COUNTRY, 2020–2030(%)
FIGURE 14.FERTILITY SUPPLEMENTS MARKET REVENUE FOR POWDERS, BY COUNTRY, 2020–2030(%)
FIGURE 15.FERTILITY SUPPLEMENTS MARKET REVENUE FOR LIQUIDS, BY COUNTRY, 2020–2030(%)
FIGURE 16.FERTILITY SUPPLEMENTS MARKET REVENUE FOR MEN, BY COUNTRY, 2020–2030(%)
FIGURE 17.FERTILITY SUPPLEMENTS MARKET REVENUE FOR WOMEN, BY COUNTRY, 2020–2030(%)

Purchase Full Report of
Fertility supplement market by Ingredient

PURCHASE OPTIONS



* Taxes/Fees, If applicable will be added during checkout. All prices in USD.

Have a question ?

Need to add more ?

Avail up to 30% discount on subscription plans on


Avenue